Streptokinase is an enzyme produced by certain strains of the bacterium Streptococcus. It acts as a fibrinolytic agent, promoting the breakdown of blood clots by converting plasminogen into plasmin, which dissolves fibrin. Streptokinase is primarily used in medical settings to treat conditions like myocardial infarction (heart attack) and pulmonary embolism. However, its use has declined with the advent of more targeted thrombolytic agents and concerns about allergic reactions.
Streptokinase and tissue-type plasminogen activator are used for:
Streptokinase is naturally produced by the bacteria group A streptococcus (Streptococcus pyogenes).
Streptokinase and tPA are both thrombolytics, meaning that they break up clots.
FFP i think.
Aminocaproic acid is not the antidote for streptokinase. Aminocaproic acid is used to treat excessive bleeding or to prevent clot dissolution, while streptokinase is a clot-dissolving medication used to treat conditions like heart attacks and strokes.
Clot buster.
Michael Martin has written: 'Streptokinase in chronic arterial disease' -- subject(s): Arterial occlusions, Arteries, Chemotherapy, Chronic diseases, Stenosis, Streptokinase, Therapeutic use
Streptokinase and tissue-type plasminogen activator are both thrombolytic medications used to dissolve blood clots in the body. They are commonly used to treat conditions such as heart attacks, strokes, and pulmonary embolisms by restoring blood flow in blocked arteries or veins.
ECg MONITOR bleeding, bradycardia
"Thrombolysed" means breaking down or dissolving a blot clot. "Streptokinase" is a drug that is used to break down blot clots. For example, this may be done to treat a heart attack, where a blot clot is blocking the flow of blood to part of the heart.
Streptokinase specifically targets fibrin due to its ability to bind to plasminogen, converting it into plasmin, which then digests fibrin in blood clots. This action is selective because fibrin is a component of blood clots, whereas healthy tissues do not contain significant amounts of fibrin. Additionally, the enzymatic activity of plasmin is primarily aimed at fibrin and does not have the same affinity for other tissue components. Thus, while there is a risk of some collateral damage, the primary action of streptokinase is to dissolve fibrin in clots.
It is a Thromolytic used to dissolve blood clots to revive patients during a heart attack. It is the commercial name given to Streptokinase.